- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03313765
MI-based PrEP Intervention
August 24, 2021 updated by: The Miriam Hospital
A Brief Motivational Interviewing-based Intervention to Improve HIV Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men
Gay, bisexual and other men who have sex with men (MSM) are the group at highest risk of HIV infection in the United States.
Pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in preventing HIV infection among MSM.
However, uptake in clinical settings has been slow for several reasons, including low awareness and education, low perceived HIV risk, concern for side-effects, and stigma associated with taking the medication.
The purpose of the proposed study is to develop and evaluate a brief motivational interviewing (MI) intervention to promote PrEP uptake among MSM during the course of routine HIV screening at a public sexually transmitted disease (STD) clinic.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- The Miriam Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- 18 years of age or older
- Assigned male at birth and currently identify as male
- Score at least 10 on the HIV Incident Risk Index for MSM
- HIV-negative based on results of antibody test
- English- or Spanish-speaking
- Have access to a working phone
- Have not taken PrEP
Exclusion Criteria:
- Have previously taken PrEP
- Symptoms of acute HIV infection at baseline
- HIV positive
- A clinical contraindication to PrEP (e.g., renal dysfunction)
- Non-English or non-Spanish speaking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
|
Brief MI intervention
|
|
Active Comparator: Standard-of-care
|
Standard-of-care education and counseling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
PrEP uptake
Time Frame: Three months
|
Three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philip A Chan, MD, Brown University/The Miriam Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 10, 2019
Primary Completion (Actual)
April 30, 2020
Study Completion (Actual)
April 30, 2020
Study Registration Dates
First Submitted
October 13, 2017
First Submitted That Met QC Criteria
October 17, 2017
First Posted (Actual)
October 18, 2017
Study Record Updates
Last Update Posted (Actual)
August 25, 2021
Last Update Submitted That Met QC Criteria
August 24, 2021
Last Verified
March 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- R34DA042648 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PrEP Uptake
-
The University of Texas Health Science Center,...Merck Sharp & Dohme LLCCompletedPrEP Uptake Perspectives | PrEP Uptake Experiences | PrEP Adherence Perspectives | PrEP Adherence ExperiencesUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)CompletedPrEP UptakeUnited States
-
Centre for Infectious Disease Research in ZambiaUniversity of Washington; Fogarty International Center of the National Institute...Completed
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
University of ChicagoNorthwestern University; Ann & Robert H Lurie Children's Hospital of Chicago; Howard Brown Health Center and other collaboratorsRecruiting
-
Brown UniversityCompletedAdherence, Medication | Stimulant Abuse | PrEP UptakeUnited States
-
University of California, San DiegoCompletedHIV Seronegativity | PrEP UptakeUnited States
-
University of FloridaNational Institute on Drug Abuse (NIDA)Not yet recruitingDrug Use Disorders | PrEP Uptake | HIV Risk Behavior | PrEP Adherence
-
Yale UniversityGilead SciencesNot yet recruitingHIV Prevention | PrEP Uptake | PrEP AwarenessUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
Clinical Trials on Motivational interviewing (MI)
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEnd Stage Renal Disease on DialysisUnited States
-
University of IowaCompletedSelf-efficacyUnited States
-
Chinese University of Hong KongThe University of Hong KongCompleted
-
Western University, CanadaRecruitingHead and Neck Cancer | SurvivorshipCanada
-
University of Illinois at Urbana-ChampaignUniversity of WashingtonNot yet recruiting
-
Northeastern UniversityCompleted
-
Brigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedOsteoarthritis | Degenerative Joint DiseaseUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedAcute Coronary SyndromeUnited States
-
University of VermontAfrica Mental Health FoundationCompletedAlcohol Use Disorder